Fig. 1From: Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot studyEnrollment. Twenty participants were included in the final analysis. Two completed only 6Â weeks of the study and received 2Â weeks of placebo and 4Â weeks of sodium bicarbonateBack to article page